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The human heart cannot regenerate after an injury. Lost cardiomyocytes are replaced by scar tissue
resulting in reduced cardiac function causing high morbidity and mortality. One possible solution to this
problem is cardiac tissue engineering. Here, we have investigated the suitability of non-mulberry silk
protein ﬁbroin from Indian tropical tasar Antheraea mylitta as a scaffold for engineering a cardiac patch
in vitro. We have tested cell adhesion, cellular metabolic activity, response to extracellular stimuli, cell-
to-cell communication and contractility of 3-days postnatal rat cardiomyocytes on silk ﬁbroin. Our data
demonstrate that A. mylitta silk ﬁbroin exhibits similar properties as ﬁbronectin, a component of the
natural matrix for cardiomyocytes. Comparison to mulberry Bombyx mori silk protein ﬁbroin shows that
A. mylitta silk ﬁbroin is superior probably due to its RGD domains. 3D scaffolds can efﬁciently be loaded
with cardiomyocytes resulting in contractile patches. In conclusion, our ﬁndings demonstrate that
A. mylitta silk ﬁbroin 3D scaffolds are suitable for the engineering of cardiac patches.
 2011 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Cardiovascular diseases (CVD) remain among the leading causes
of death worldwide. The underlying mechanism of most CVD is the
loss of cardiomyocytes that cannot be replaced with newly formed
cardiomyocytes based on homeostatic mechanisms [1]. Car-
diomyocyte death leads to reduced heart function, a diminished
quality of life and inevitable progression to overt heart failure.
Current treatment of congestive heart failure attempting to mini-
mize cardiomyocyte death has reduced early mortality from
myocardial infarction. However, despite considerable progress in
the treatment of heart failure, mortality rates are still high with as
much as 30% within one year [2]. One reason for this poor prog-
nosisis the limited options to replace damaged or lost cardiac tissue
other than organ transplantation. It is expected that the burden of
CVD will increase in the future as life expectancy and the incidence
of cardiac risk factors like obesity and diabetes increases. The high
morbidity, mortality and cost associated with CVD necessitate theogy, Indian Institute of Tech-
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C. Kundu), felix.engel@mpi-
-NC-ND license.development of improved treatments to prevent, treat and reverse
heart disease. One solution to this problem might be the engi-
neering of 3D cardiac tissues outside of the body that can be
adjusted according to the needs of a patient before implantation.
One of the ﬁrst approaches was the embedment of cardiomyocytes
in a mixture of type I collagen gel and Matrigel. These engineered
cardiac tissues improved left ventricular function after myocardial
infarction and proved that implantation of engineered tissue can
indeed be used to treat CVDs [3]. However, this and similar
approaches appear to be suboptimal regarding clinical applicability.
Collagen gels [4] and foams [5] are characterized by mechanical
weakness and random microstructures [6]. Synthetic polymers in
addition exhibit often excessive stiffness [7,8]. An alternative
approach is the use of the natural environment. For this purpose,
hearts were decellularized with sodium dodecyl sulfate (SDS) and
repopulated [9]. This approach resulted in functional 3D cardiac
tissue, however, it exhibited high mechanical stiffness likely due to
extracellular matrix compaction or through alterations of the
extracellular matrix due to SDS treatment [9]. Thus, a new focus in
the ﬁeld is the development of advanced material strategies with
an emphasis on mimicking native structural, mechanical, and
transport properties by microfabricating an accordion-like honey-
comb scaffold [10]. However, so far there is no approach available
for the generation of clinically applicable 3D cardiac tissue patches.
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gradable scaffold that mimics the in vivo extracellular matrix which
enables cells to attach, migrate, grow and function properly [11]. A
great variety of natural (collagen, hyaluronan, chitosan, cellulose,
mulberry silk) and synthetically formulated materials have been
tested for 3D scaffold constructions [12]. Synthetic materials are
cheap, reproducible and easy to manufacture but their degradation
products are often toxic and cause chronic inﬂammation [13].
Materials of natural origin are recognized by the in vivo biological
environment and are degraded through established metabolic
processes [14]. However, they often cause a host immunogenic
response that results in implant rejection.
Amongst the natural biomaterials available, silkworm silk
protein ﬁbroin possesses unique mechanical strength, biocompat-
ibility [15e19] and relative ease in fabrication into diverse
morphologies [20]. Antheraea mylitta silk protein ﬁbroin scaffolds
(2%) measuring 10 mm in diameter and 10 mm in height showed
a compressive strength of 84 kPa [21]. This observed strength is
higher than other reported naturally derived materials used for 3D
scaffold fabrication (e.g. collagen and chitosan scaffolds have
a mechanical strength of 15 kPa and 45 kPa, respectively) [22].
Scaffolds of 6.4 mm in diameter and 0.2 mm thickness showed
compressive modulus of 5.2 kPa at frequency of 0.005 Hz, and
dynamic stiffness of 8 kPa at frequency of 1.5 Hz [17]. Non-mulberry
silk protein ﬁbroin is mechanically superior to mulberry silk [21]
and possesses RGD sequences (GenBank: AY136274.1) [23]. Its
non-cytotoxic property and low level of inﬂammatory response
[24,25] make it an excellent material for tissue engineering.
In this study, we have evaluated the potential of silk protein
ﬁbroin of Indian tropical tasar silkworm A. mylitta (AM) as bioma-
terial for in vitro 3D cardiac tissue engineering using 3-days post-
natal cardiomyocytes by analyzing cellular metabolic activity, cell-
to-cell communication, cell cycle activity and contractility. For
comparison we utilized silkworm Bombyx mori silk ﬁbroin (BM),
gelatin and ﬁbronectin.2. Materials and methods
2.1. Rat neonatal cardiomyocyte isolation and cell culture
Animal experiments were approved by the local Committee for Care and Use of
Laboratory Animals (Regierungspräsidium Darmstadt, Gen. Nr. B 2/202) and
conform to the Guide for the Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Ventricular cardiomyocytes were isolated from 3-days-old (P3) Sprague Dawley rats
as described [26]. For selective enrichment of cardiomyocytes, cells were preplated
for 2 h (2 mM L-glutamine, 10% FBS and 100 U/mg/ml Pen/Strep in DMEM/F12
medium). Non-attached cells were collected, centrifuged, resuspended in neonatal
cardiomyocyte medium (3 mM Na pyruvate, 2 mM L-glutamine, 0.1 mM ascorbic
acid, 1 mg/ml insulin/transferrin/selenium, 0.2% BSA and 100 U/mg/ml Pen/Strep in
DMEM/F12 medium) supplemented with 5% horse serum and seeded in 500 ml per
24-well for 48 h if not stated otherwise. Cells were cultured at 37 C in a 5% CO2/95%
air humidiﬁed atmosphere.2.2. Preparation of silk protein ﬁbroin solution
Indian tropical tasar A. mylitta silk larvae were obtained from Tasar Sericulture
Farm, West Midnapur of West Bengal State of India. Silk protein ﬁbroin from
A. mylitta and B. mori silkworms and cocoons were prepared as described previously
[27,28]. In brief, ﬁbroin protein was collected by squeezing excised silk glands from
fully-grown A. mylitta larvae after washing with distilled water. Fibroin was dis-
solved in 1%(w/v) SDS aqueous solution containing 10 mM Tris (pH 8.0) and 5 mM
EDTA. Isolated ﬁbroin protein was either used immediately or stored at 20 C.
Fibroin protein from B. mori silkwormwas prepared from the cocoon. Sericin protein
was removed from cocoons by boiling in a 0.02 M Na2CO3 solution for 1 h. After
thoroughly rinsing with distilled water the degummed ﬁbroin ﬁbers were dissolved
in 9.3 M LiBr solution at 60 C and dialyzed (MWCO 12000) against distilled water
for 3 days. Fibroin concentration was adjusted to 2% (w/v) by adding distilled water.2.3. Fabrication of 3D silk ﬁbroin scaffolds
The silk ﬁbroin solutions (2% w/w) from both A. mylitta silk gland and B. mori
cocoons were cast into moulds, frozen at20 C for 8 h and then lyophilized to yield
porous 3D silk ﬁbroin scaffolds, having a diameter of 13mm and a thickness of 2 mm
[18]. The lyophilized silk ﬁbroin scaffolds were analyzed by scanning electron
microscopy. The size of 30 random pores per scaffold was determined by Image J
software.
2.4. Coating procedure for 2D cell culture
Glass coverslips (B 12 mm, Karl Hecht GmbH, Germany) were placed in 24-well
tissue culture plates, washed oncewith 70% ethanol and twice with 100% ethanol for
3 min. Air-dried coverslips were incubated with 100 ml of 10 mg/ml ﬁbronectin
(PromoCell, Germany)/PBS or 0.5% (w/v) silk ﬁbroin/PBS or 1% (w/v) gelatin (Sigma)/
water for 2 h at 37 C. Solutions were aspirated and coverslips were treated for
30 min with UV light before cardiomyocytes were seeded.
2.5. Immunohistochemistry
Parafﬁn sections (5 mm) were deparafﬁnized and rehydrated following standard
protocols [29]. Antigen retrieval was achieved by boiling sections in 1 mM EDTA
(pH 8.0) for 8 min. Cultured cells were ﬁxed in 3.7% formaldehyde (Sigma) for
15 min. All antibodies were diluted in blocking buffer as indicated, and all manip-
ulations were carried out at room temperature. Samples were permeabilized
for 10 min with 0.5% Triton X-100/PBS. For BrdU incorporation assays, cells
were incubated for 30 min in 2 N HCl/1%Triton X-100 after permeabilization.
Samples were blocked for 20 min with 5% goat serum/0.2% Tween 20/PBS and
incubated for 1 h with primary antibodies (mouse monoclonal anti-sarcomeric
a-actinin, rat monoclonal anti-BrdU, 1:100, Abcam, rabbit polyclonal anti-
connexin 43 and anti-troponin I, 1:50, Santa Cruz Biotechnology). Immune
complexes were detected with ALEXA 488- or ALEXA 594-conjugated antibodies
(1:200, Molecular Probes). DNAwas visualized with DRAQ-5 (Cell Signaling) or 40 ,60-
diamidino-2-phenylindole (DAPI, Sigma) (0.5 mg/ml PBS). Fluorescent images were
obtained using a Leica ﬂuorescent microscope or a Zeiss LSM 710 confocal laser-
scanning microscope.
2.6. Cell adhesion assay
Coated coverslips were seeded with 1.2  105 cells. Cell adhesionwas quantiﬁed
by determining the average number of attached cells from 10 randomly chosen
microscopic ﬁelds at indicated time points.
2.7. Cellular metabolic activity
To examine cell viability and cytocompatibility on different 2D matrices
0.4  105 cells were seeded and cultured up to 8 days with media changes every 2
days. MTT assay (Sigma) was performed after 2, 4, 6 and 8 days.
2.8. Arg-Gly-Asp-Ser (RGDS) assays
Isolated cardiomyocytes were incubated for 30 min in culture medium con-
taining either 300 mM of an Arg-Gly-Asp-Ser (RGDS) peptide (Calbiochem, La Jolla,
CA) or an Arg-Gly-Glu-Ser (RGES) peptide (American peptide Company, Sunnyvale,
CA) as control at 37 C incubator in a 5% CO2/95% air humidiﬁed atmosphere.
Subsequently cells were seeded for 24 h or 48 h in presence of the peptides.
2.9. Cell cycle activity
Coated coverslips were seeded with 0.8  105 cells. After 48 h, cells were
cultured either in neonatal medium containing 5% horse serum or 50 ng/mlFGF1
(R&D Systems). SB 203580 HCl (p38i) (Tocris) was added freshly every day for 2 days
and BrdU (30 mM, Sigma) for the last 24 h. Cell cycle activity was quantiﬁed 48 h
after stimulation by counting >500 cardiomyocytes from >7 randomly chosen
microscopic ﬁelds per experiment.
2.10. Generation of cardiac tissue
Silk ﬁbroin scaffolds were placed in 6-well plates, treated with 70% ethanol/
dH2O for 30 min, washed with PBS and incubated for at least 2 h in neonatal
medium. Scaffolds were then seeded with 5  106 cardiomyocytes suspended in
100 ml neonatal medium supplemented with 10% fetal calf serum (FCS) per 1 cm3
scaffold and were incubated for 2 h at 37 C in a 5% CO2/95% air humidiﬁed
atmosphere. Subsequently, the amount of medium was increased to immerse the
loaded scaffolds, which were incubated up to 3 weeks with media changes every
second day.
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Movies of beating cardiomyocytes or beating scaffolds were recorded with
a Sony HDR-SR12 camcorder and formatted (Wondershare or iSkysoft video
converter).
2.12. Statistical analysis
Data are expressed as the mean  SEM of at least three independent experi-
ments. Statistical signiﬁcance of differences was evaluated by one way ANOVA fol-
lowed by Bonferroni’s post-hoc test (GraphPad Prism). p < 0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Attachment of cardiomyocytes
One criterion for choosing a material to engineer tissue is its cell
adhesive properties. Therefore, we compared the properties of
A. mylitta (AM) and B. mori (BM) silk ﬁbroin in 2D culture with
gelatin and ﬁbronectin in regards to adhesion of primary 3-days
postnatal rat cardiomyocytes. Gelatin is a cheap matrix that is
commonly used for in vitro cardiomyocyte cultures even though it
has rather poor adhesive properties. Fibronectin is a natural matrix
for cardiomyocytes during heart development and a well-
established coating material for neonatal cardiomyocyte attach-
ment [30,31]. Therefore, it has been used in this study as positive
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positive cardiomyocytes (B) and non-myocytes (C) (n ¼ 3, mean  SEM, *: p < 0.05). Scale ba
is referred to the web version of this article.)After cell isolation and cardiomyocyte enrichment, cells were
allowed to attach for 6, 30 and 48 h. Cell counting experiments after
troponin I/DAPI staining revealed that the vast majority of non-
myocytes (troponin I-negative) attached within the ﬁrst 6 h inde-
pendently of the utilized matrices (Fig. 1A,C). In contrast, car-
diomyocyte attachment was dependent on time and matrix. After
6 h signiﬁcantly more cardiomyocytes attached on AM compared to
BM and gelatin. Moreover, therewas no difference between AM and
the positive control ﬁbronectin (Fig. 1A,B). At 48 h the majority of
cardiomyoctes had attached to all four matrices whereas signiﬁ-
cantly more cardiomyocytes attached on gelatin, AM and ﬁbro-
nectin compared to BM. Taken together, these data demonstrate
that AM is a good substrate for cardiomyocyte attachment. This was
further supported by the observation that spreading of car-
diomyocytes after 30 h was clearly visible on AM and ﬁbronectin
but not on BM or gelatin (Fig. 1A, arrow heads).3.2. Metabolic activity of cardiomyocytes
MTTassay was performed to determine the cytocompatibility of
silk with cardiomyocytes. This assay is an indirect measurement of
the cellular metabolic activity and was performed on neonatal
cardiomyocytes cultured for up to 8 days on the indicated 2D
substrates. Cardiomyocytes grown on AM and ﬁbronectin exhibited
similar metabolic activity at all investigated time points, which was
signiﬁcantly higher than the activity of cardiomyocytes grown onh
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C. Patra et al. / Biomaterials 33 (2012) 2673e26802676gelatin or BM at days 2, 4 and 6 (Fig. 2A). At 8 days of culture we
observed no signiﬁcant difference among cultures plated on
gelatin, AM and ﬁbronectin. However, the metabolic activity of
cultures on BM remained signiﬁcantly lower. The distribution of
cardiomyocytes was at day 8 comparable among the different
matrices (Fig. 2B). Thus, AM had in contrast to BMno negative effect
on the metabolic activity of cardiomyocytes and was comparable to
the natural matrix protein ﬁbronectin.
3.3. RGD-dependency of cardiomyocyte attachment
Naturally occurring AM contains, like ﬁbronectin, several RGD
sequences [23,32]. Previously, it has been shown that presence of
RGD sequences in natural as well as synthetic material promotes
cell adhesion and spreading via activation of cell surface integrin
receptors [33]. In contrast, gelatin and BM are devoid of RGD
sequence. To evaluate whether the observed advantages of AM and
ﬁbronectin over BM and gelatin are indeed due to the RGD
sequences we performed blocking assays with RGDS peptides. To
block all cell surface molecules that can interact with RGD
sequences we incubated the enriched cardiomyocyte cultures
before seeding for 30minwith RGDS peptides. As a control we used
the highly similar RGES peptide that does not block RGD binding
sites. We performed MTT assays to measure cellular activity at 24
and 48 h and set in the control (incubationwith RGES) the "Relative
cellular metabolic activity" for each matrix (gelatin, AM, ﬁbro-
nectin) to 100%. Incubation of cells with RGDS peptides had in
comparison to incubation with the RGES peptides no effect on
cellular metabolic activity of cell cultures on gelatin (Fig. 3). In
contrast, there was a signiﬁcant reduction in activity on AM
(100  10.2% to 66  10.5%) and ﬁbronectin (100  7.8% to
73.4  6.0%) at 24 h (Fig. 3A). At 48 h RGDS peptide incubation
reduced the metabolic activity in cultures grown on AM
(100  23.1% to 59.7  8.9%) but not in cultures grown on ﬁbro-
nectin (Fig. 3B). In conclusion, our data indicate that the cellular
activity of cardiomyocytes on AM depends on its RGD sequences.
The RGD sequence can mediate cell adhesion and is thus often
employed to improve adhesion on biomaterials [33,34]. Thus, the
measured reduced cellular metabolic activity after RGDS peptide
incubation might be due to reduced cardiomyocyte attachment. ToGe
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(For interpretation of the references to colour in this ﬁgure legend, the reader is referred tdetermine the effect of RGDS peptide incubation on cell attachment
isolated and enriched cardiomyocytes were allowed to attach for
24 h after 30 min incubation with RGDS or RGES peptides. Incu-
bation with the RGDS peptide inhibited signiﬁcantly the number of
attached cardiomyoctes on AM but not on gelatin or ﬁbronectin
(Fig. 3C,D). In addition, we observed that spreading of car-
diomyocytes was inhibited on AM as well as ﬁbronectin (Fig. 3C).
3.4. Characterization of growth factor-induced cell cycle activity
In order to engineer cardiac tissue it is important to determine
that cardiomyocytes seeded on the chosen matrix respond normal
to extracellular stimuli. Therefore, we have stimulated car-
diomyocytes with horse serum (HS) as well as ﬁbroblast growth
factor 1 (FGF1) plus an inhibitor of the mitogen-activated protein
kinase p38 (p38i) that are known to induce cell cycle activity [35].
Stimulation with horse serum results usually in a low activation of
DNA synthesis in cardiomyocytes seeded on gelatin (12.1  4.4%)
(Fig. 4). We observed no signiﬁcant difference for cardiomyocytes
seeded on AM (18.4  4.5%) and BM (15.6  3.8%). However, there
was a trend towards a better induction on AM.
Stimulationwith FGF1/p38i is a strong inducer of cardiomyocyte
cell cycle activity and induced BrdU incorporation in 32.0  1.7% of
cardiomyocytes seeded on gelatin (Fig. 4A,C). There was no signif-
icant difference to cells seeded on BM (36.8  7.0%). In contrast,
stimulation of cardiomyocytes on AM and ﬁbronectin was signiﬁ-
cantly more effective (44.8  6.6%, 46.5  5.5% respectively). These
data suggest, that AM does not interfere with the responsiveness of
cardiomyocytes to extracellular signals.
3.5. Cell-to-cell communication and contractility
In order to generate a cardiac tissue it is not only important that
cardiomyocytes attach and react to extracellular stimuli but also are
able to couple with their neighboring cells and beat synchronously
exhibiting a high contractility. In order to exhibit a high contrac-
tility it is crucial that cardiomyocytes exhibit well-differentiated
sarcomeres that are aligned in parallel. Immunoﬂuorescence
analysis based on troponin I demonstrates that sarcomeres in car-
diomyocytes grown on AM and ﬁbronectin contain clearly visibleys
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C. Patra et al. / Biomaterials 33 (2012) 2673e2680 2677aligned sarcomeres (Fig. 5A). In contrast, the sarcomeres in car-
diomyocytes grown on gelatin as well as BM appeared immature
and were mainly not aligned.
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C. Patra et al. / Biomaterials 33 (2012) 2673e26802678contraction and relaxation cycles permin indicated that the beating
frequency of cardiomyocytes does not depend on the matrices
(Fig. 5C). However, in accordance to the connexin 43 data, car-
diomyocyte cultures grown on gelatin and BM did not beat
synchronously. On gelatin one can observe that neighboring car-
diomyocytes beat independently of each other (Supplementary
Movies 1). On BM, even at high cellular density, only a subset of
cardiomyocytes couple with each other whereas the remaining
cardiomyocytes beat independently (Supplementary Movies 2). In
contrast, cardiomyocytes on AM or ﬁbronectin contracted
synchronously (Supplementary Movies 3 and 4). In summary, AM
promotes sarcomere maturation and alignment, cell-to-cell
communication and synchronous contractions.
Supplementary video related to this article can be found at doi:
10.1016/j.biomaterials.2011.12.036.3.6. Characterization of 3D cardiac tissue constructs
After obtaining promising results in 2D, we attempted to engi-
neer 3D cardiac tissues. 3D AM scaffolds were fabricated, loaded
with cardiomyocytes and analyzed. 3D AM scaffolds were prepared
by lyophilization of a 2% AM solution. A quantitative analysis of
scanning electron micrographs of the cell-free scaffolds demon-
strated that the pore size varies from 30 mm2 to 160 mm2 (Fig. 6A,B).
To evaluate the cell attachment and distribution on the scaffold
we performed laser scanning microscopic analyses of scaffolds that
were stained for cardiomyocytes (troponin-I) and nuclei (DRAQ5) 8
days after cardiomyocyte loading. The walls of the scaffold were
visible in blue due to autoﬂuorescence. This analysis revealed that
cardiomyocytes were attached uniformly on the wall of the pores(Fig. 6C) containing well-organized and aligned sarcomeres
(Fig. 6D; arrow head).
Finally, we were interested whether cardiomyocyte loading of
3D AM scaffolds results indeed in contractile 3D tissue. Immuno-
ﬂuorescence analyses of 5 mm thin parafﬁn sections taken from the
center of scaffolds 8 days after loading stained for sarcomeric a-
actinin and connexin 43 demonstrated that cardiomyocytes
attached throughout the scaffold expressing connexin 43 (Fig. 6E).
Hematoxylin and Eosin (H&E)-stained sections at 8 and 20 days
conﬁrmed the distribution throughout the scaffold. This suggested
that AM scaffolds are non-toxic and allow long-term culture
of cardiomyocytes (Fig. 6F). Accordingly, we observed that
cardiomyocyte-loaded AM scaffolds beat in culture for at least 20
days. Quantitative analysis shows that scaffolds beat synchronously
with a frequency of 51.4  5.6 per minute at day 8 (Fig. 6G and
Supplementary Movie 5 and 6).
Supplementary video related to this article can be found at doi:
10.1016/j.biomaterials.2011.12.036.4. Discussion
The generation of cardiac tissue is highly challenging as the
heart is constantly contracting and thus demands special
mechanical properties from the utilized scaffold. Additional strat-
egies to repair the heart after injury include regeneration through
stem cells [37] or induction of cardiomyocyte proliferation [1],
organ- or xenotransplantation [38]. Similar to tissue engineering
these approaches are mainly far from translation to clinic or they
appear to be not yet efﬁcient in improving heart function. The
relative paucity of techniques currently available to repair the
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Fig. 6. 3D A. mylitta silk ﬁbroin scaffolds for cardiac tissue engineering. (A) Example of bright ﬁeld and scanning electron microscopic pictures of A. mylitta silk ﬁbroin scaffolds. Scale
bar: 2 mm (red); 50 mm (yellow). (B) Quantitative analysis of pore sizes of 3D scaffolds. (C) Projection of confocal images of a cardiomyocyte loaded scaffold stained for troponin I
(cardiomyocytes, green) and Draq5 (nuclei, blue). Scale bar: 30 mm. (D) Note that cardiomyocytes attach and exhibit well-organized and aligned sarcomeres (white arrow heads).
5 mm thick projection. Blue stars: scaffold. Scale bar: 15 mm. (E) Hematoxylin and Eosin (H&E)-stained sections of 3D loaded scaffolds at 8 and 20 days indicating the biocompatibility
of A. mylitta silk ﬁbroin. Scale bar: 50 mm. (F) Examples of cardiomyocyte-loaded scaffold sections at 20 days stained for connexin 43 (red), sarcomeric a-actinin (green) and DAPI
(blue). Note that cardiomyocytes on A. mylitta silk ﬁbroin express connexin 43 (yellow arrow heads) suggesting cell-to-cell communication. Scale bar: 25 mm. (G) Quantitative
analysis of the beating frequency of cardiomyocyte loaded A. mylitta silk ﬁbroin 3D scaffolds at 8 days. (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article.)
C. Patra et al. / Biomaterials 33 (2012) 2673e2680 2679mammalian heart necessitates the development of more effective
clinical strategies. Our data suggest that silk ﬁbroin from A. mylitta
provides a new platform for the development of cardiac therapies.
Silk ﬁbroin from B. mori has extensively been studied and shown
to provide a surface on which a variety of cell types like osteoblast,
keratinocyte, ﬁbroblasts, nerve cells, mesenchymal stem cells,
endothelial cells can grow on [15]. It can be used in its pure form or
as ﬁlms, membranes, gels, sponges, nanoparticles and 3D scaffolds
making it useful for enzyme immobilization, drug delivery and
tissue engineering [15]. In conclusion, silk ﬁbroin has been
demonstrated due to its mechanical properties, biodegradability,
cytocompatibility, low immunogenicity and controllable porosity
to have a great potential to solve a wide range of biomedical
problems [15,16].
In previous years Kundu and co-workers have established silk
ﬁbroin from Indian tropical tasar silkworm A. mylitta (AM) and
shown that it has excellent properties as a biomaterial in terms of
cell adhesion, migration, differentiation and proliferation of
a number of different cell types [17]. AM is superior to BM in respect
to mechanical properties like elasticity and tensile strength [21].
These properties make it an ideal candidate material for the
generation of contractile tissue like cardiac patches.
For regenerative therapy it is important that the biomaterial is
tolerated by the host immune system. The body responds to foreign
material depending on its surface topography not its chemical
composition [39]. Smooth surfaces induce strong inﬂammatory
reactions, which lead to scarring and the development of a ﬁbrotic
capsule around the implant. In contrast, rough surfaces diminish
innate immune reaction and prevent implant rejection after
transplantation. Surface topography analysis has shown that ﬁlm as
well as thread from A. mylitta ﬁbroin is rougher than ﬁbroin from
B. mori [40].
In order to develop a biomaterial for tissue engineering it is
important to get adequate interaction between cells and polymer
[41]. Cardiomyoctes are characterized by poor attachment torandom surfaces and rather slow attachment and spreading even
to components of its natural in vivo matrix. Our data clearly
demonstrate that cardiomyocytes attach and spread much faster
on AM than BM. As cardiomyocytes on AM responded to extra-
cellular stimuli in the same way as cardiomyocytes attached to
ﬁbronectin the interaction between cells and AM appears to be
adequate.
The observed differences between AM and BM might be due to
the fact that AM in contrast to BM possesses repeating RGD
sequences [23]. The RGD sequence is the most often employed
peptide to stimulate cell adhesion on different biomaterials, as it is
a ligand of the cell adhesion integrin receptor family. It has been
shown that about half of the 24 integrin receptors recognize the
RGD sequence [33,34]. This interaction not only has a role for cell
anchoring but also is also important for wound healing, immune
response and cell differentiation. Incorporation of RGD sequences
in BM has demonstrated to promote cell adhesion properties in
chrondocytes [42]. Our data demonstrate that RGD domains in AM
are required for cardiomyocyte attachment by incubating cardiac
cells with RGDS peptides.
3DAM scaffold loadedwith cardiomyocytes spontaneously beat.
Cardiomyocytes on 2D AM express higher levels of the gap junc-
tional protein connexin 43 than on BM. This expressionwas similar
to expression in cardiomyocytes on ﬁbronectin and was also
observed in 3D AM scaffolds. Moreover, sarcomeres in car-
diomyoctes loaded on 3D AM scaffolds were aligned. These data
suggest that AM enables cardiomyocyte maturation which might
promote contractile strength and electrical coupling of the implant
with the host myocardium.
In the future it will be important to further optimize the
loading of the AM scaffold with cardiomyocytes but also non-
myocytes, to investigate how pore size of the scaffold will affect
cell behavior including migration,to challenge the AM-based
cardiac tissue to improve its contractility and ﬁnally to perform
in vivo studies.
C. Patra et al. / Biomaterials 33 (2012) 2673e268026805. Conclusion
A. mylitta silk ﬁbroin (AM) enables efﬁcient attachment
of cardiomyocytes without affecting their response to extracellular
stimuli. Cardiomyocytes growing on AM express connexin
43, exhibit aligned sarcomeres and couple electrically with
each other resulting in synchronous beating. The generated
cardiac tissues are stable and spontaneously beat for at least 20
days. In conclusion, our ﬁndings together with the known in vivo
properties of silk suggest that AM 3D scaffolds may be suitable for
the establishment of therapies for cardiac disease requiring
mechanical support and therefore warrants further preclinical
investigation.
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